The worldwide diabetic ketoacidosis therapy market was valued at USD 1,500 million in 2021 and is expected to reach over USD 2,500 million by 2030, with a CAGR of 6.5% during the forecast period. A lack of insulin in the body causes an excessive buildup of ketone acids in the blood, which is known as diabetic ketoacidosis (DKA). When a diabetic patient has a severe hyperglycemic...